Walgreens to go private in $10B deal
Published On Mar 6, 2025, 6:10 PM
Walgreens Boots Alliance has announced a $10 billion deal to become a private company, partnering with Sycamore Partners at a price of $11.45 per share, representing an 8% premium on its recent stock price. The deal aims to grant Walgreens more flexibility to make significant business adjustments, particularly in response to ongoing challenges within the pharmacy sector and stiff competition from online retailers. Additionally, shareholders could potentially receive up to $3 more based on the monetization of Walgreens' interests in VillageMD. The company has seen its market value plummet drastically over the last decade due to increased competition and falling margins in drug pricing.
Stock Forecasts
WBA
Positive
The deal, which allows Walgreens to operate privately, may enable cost-cutting measures and strategic restructuring that could improve its competitive stance in a challenging market. The premium offered indicates some investor confidence in the turnaround potential under private management.
Related News
S&P 500 gives up gain, Dow falls as White House says tariffs starting Saturday: Live updates
Jan 30, 2025, 6:01 PM
Stocks pulled back on Friday as investors digested news that Trump tariffs on Canada, Mexico and China would begin on Saturday.
Stock market today: Dow, S&P 500, Nasdaq sink amid jobs report surprise, fresh inflation worries
Jan 10, 2025, 4:03 PM
Caution reigns ahead of December's jobs report, which will shape bets on the chances of Fed rate cuts.
Walgreens could 'aggressively' cut costs if privately owned, analyst says
Dec 11, 2024, 8:27 AM
Walgreens will have more freedom to aggressively cut costs if it becomes privately owned, one industry analyst said. The company is reportedly in talks with Sycamore Partners.